PharmGen Science, Inc. (KRX:004720)
South Korea · Delayed Price · Currency is KRW 4,405.00
+75.00 (1.73%)
Last updated: Oct 2, 2025, 9:00 AM KST
PharmGen Science Market Cap
PharmGen Science has a market cap or net worth of 82.32 billion as of October 6, 2025. Its market cap has decreased by -4.65% in one year.
Market Cap
82.32B
Enterprise Value
87.66B
Revenue
171.66B
Ranking
n/a
PE Ratio
699.07
Stock Price
4,405.00
Market Cap Chart
Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 82.32B, an increase of 655.75%. That is a compound annual growth rate of 6.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 82.32B | 10.97% |
| Dec 30, 2024 | 74.18B | -33.39% |
| Dec 28, 2023 | 111.36B | 5.58% |
| Dec 29, 2022 | 105.47B | -33.88% |
| Dec 30, 2021 | 159.51B | -3.78% |
| Dec 30, 2020 | 165.78B | 123.51% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |